Ovid Therapeutics Inc.
OVID
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Ovid Therapeutics Inc., biofarmaceutická společnost, vyvíjí účinné léky pro pacienty a rodiny s neurologickými poruchami ve Spojených státech. Společnost vyvíjí OV101, lékový kandidát, který je v klinických studiích fáze 2A pro léčbu křehkého X syndromu; OV329, inhibitor GABA aminotransferázy pro léčbu záchvatů spojených s tuberózou, komplexem sklerózy a infantilními spazmy; a OV350, malou molekulu pro léčbu epilepsií. Dále vyvíjí OV882, krátkou genovou terapii vlasové RNA pro léčbu angelmanova syndromu, a OV815 pro léčbu kinesinové skupiny proteinů spojených s neurologickou poruchou. Společnost má licenční smlouvy a smlouvy o spolupráci se společnostmi Healx, AstraZeneca AB, H. Lundbeck A/S a Northwestern University, jakož i Marinus Pharmaceuticals, Inc. Společnost byla založena v roce 2014 a sídlí v New Yorku.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
23
Založení
2017-05-05
Podobné společnosti
$ 1.40
+ $ 0.03
$ 2.24
+ $ 0.05
$ 1.55
+ $ 0.32
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 7.3 | 7.3 | 0.6 | 0.4 | 1.5 | 208.4 | 12.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cost of Revenues | 0.1 | 0.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | 7.0 | 7.0 | 0.6 | 0.4 | 1.5 | 208.4 | 12.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 0.7 | 0.1 | 6.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.1 | |
| Cost of Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | -108.9 | |
| Gross Profit | 0.4 | 0.1 | 6.3 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | -0.3 | 109.0 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 28.6 | 24.6 | 46.9 | 63.4 | 42.2 | 33.8 | 50.0 | 9.6 | 6.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 31.1 | 32.4 | 37.2 | 30.6 | 19.3 | 19.1 | 15.0 | 13.0 | 6.6 | |
| Depreciation & Amortization | 0.3 | 0.3 | 0.6 | 1.6 | 1.4 | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Total Operating Expenses | 49.4 | 49.4 | 62.5 | 59.7 | 57.1 | 84.2 | 94.0 | 61.4 | 52.9 | 65.0 | 22.5 | 13.2 | |
| Operating Income | -42.4 | -42.4 | -61.9 | -59.3 | -55.5 | 124.2 | -81.4 | -61.4 | -52.9 | -65.0 | -22.5 | -13.2 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.5 | 5.3 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 7.4 | 6.8 | ||
| Depreciation & Amortization | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | ||
| Total Operating Expenses | 12.7 | 12.6 | 11.3 | 12.7 | 10.8 | 13.4 | 20.7 | 17.6 | 17.9 | 12.1 | ||
| Operating Income | -12.3 | -12.5 | -5.1 | -12.6 | -10.7 | -13.2 | -20.5 | -17.4 | -18.2 | -12.0 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 3.9 | 4.9 | 0.0 | 0.0 | 0.0 | 0.9 | 1.0 | 0.2 | 0.0 | 0.0 | |
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | -2.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 25.0 | 25.0 | 35.5 | 6.9 | 1.4 | 0.0 | 0.4 | 0.9 | 1.0 | 0.2 | 0.1 | 0.0 | |
| IBT | -17.4 | -17.4 | -26.4 | -52.3 | -54.2 | 124.2 | -81.0 | -60.5 | -52.0 | -64.8 | -22.4 | -13.2 | |
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | -2.8 | 1.3 | -0.3 | -1.2 | 1.0 | -0.1 | 0.0 | 0.0 | |
| Net Income | -17.4 | -17.4 | -26.4 | -52.3 | -51.4 | 122.8 | -80.7 | -59.3 | -52.0 | -64.8 | -22.4 | -13.2 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Interest Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1,536.1 | 0.0 | ||
| Other Expense | 22.0 | 0.4 | 0.4 | 2.3 | 1.5 | -0.8 | 29.0 | 5.7 | 2.9 | 0.8 | ||
| IBT | 9.7 | -12.2 | -4.7 | -10.2 | -9.3 | -14.0 | 8.5 | -11.7 | -15.3 | -11.3 | ||
| Income Tax Expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | ||
| Net Income | 9.7 | -12.2 | -4.7 | -10.2 | -9.3 | -14.0 | 8.5 | -11.7 | -15.3 | -11.3 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.74 | $-0.73 | $1.78 | $-1.38 | $-1.51 | $-2.11 | $-3.35 | $-1.14 | $-0.67 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.74 | $-0.73 | $1.76 | $-1.38 | $-1.51 | $-2.11 | $-3.35 | $-1.14 | $-0.67 | |
| Shares Outstanding | 81.7 | 73.7 | 70.9 | 70.6 | 70.4 | 67.5 | 58.5 | 39.2 | 24.6 | 19.3 | 19.6 | 19.6 | |
| Diluted Shares Outstanding | 81.7 | 73.7 | 70.9 | 70.6 | 70.4 | 68.1 | 58.5 | 39.2 | 24.6 | 19.3 | 19.6 | 19.6 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.22 | $-0.16 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.22 | $-0.16 | ||
| Shares Outstanding | 81.7 | 71.1 | 71.1 | 71.0 | 71.0 | 71.0 | 70.9 | 70.7 | 70.7 | 70.6 | ||
| Diluted Shares Outstanding | 81.7 | 71.1 | 71.1 | 71.0 | 71.0 | 71.0 | 71.2 | 70.7 | 70.7 | 70.6 |
| Current Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 29.7 | 26.3 | 27.0 | 129.0 | 187.8 | 72.0 | 41.9 | 36.5 | 87.1 | 51.9 | 69.9 | |
| Short Term Investments | 47.3 | 26.8 | 78.8 | 84.1 | 0.0 | 0.0 | 34.8 | 5.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 77.0 | 53.1 | 105.8 | 129.0 | 187.8 | 72.0 | 76.7 | 41.5 | 87.1 | 51.9 | 69.9 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 1.1 | 0.0 | 0.0 | 0.0 | 0.1 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Other Current Assets | 3.9 | 2.9 | 3.8 | 2.4 | 2.7 | 2.7 | 1.9 | 2.8 | 1.5 | 0.2 | 0.3 | |
| Total Current Assets | 80.9 | 55.9 | 109.6 | 131.4 | 190.5 | 74.8 | 79.8 | 44.3 | 88.6 | 52.4 | 70.3 |
| Current Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 20.6 | 28.4 | 21.1 | 26.3 | 15.0 | 29.7 | 30.8 | 27.0 | 57.4 | 71.6 | |
| Short Term Investments | 5.0 | 9.9 | 21.9 | 26.8 | 47.7 | 47.3 | 59.5 | 78.8 | 29.6 | 24.9 | |
| Total Cash & ST Investments | 25.6 | 38.3 | 43.0 | 53.1 | 62.7 | 77.0 | 90.3 | 105.8 | 87.1 | 96.5 | |
| Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Inventory | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 3.2 | 3.7 | 2.9 | 2.9 | 3.1 | 3.9 | 2.9 | 3.8 | 4.6 | 5.7 | |
| Total Current Assets | 28.8 | 42.1 | 45.9 | 55.9 | 65.8 | 80.9 | 93.2 | 109.6 | 91.7 | 102.2 |
| Long-Term Assets | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 14.0 | 13.2 | 14.7 | 16.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.1 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Long-Term Investments | 23.0 | 21.0 | 17.6 | 5.6 | 1.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Long-Term Assets | 0.2 | 1.9 | 2.0 | 2.0 | 1.9 | 0.6 | 0.5 | 2.9 | 0.8 | 0.5 | 0.0 | |
| Total Long-Term Assets | 37.2 | 36.2 | 34.4 | 23.9 | 4.1 | 1.1 | 1.0 | 3.4 | 0.9 | 0.6 | 0.1 | |
| Total Assets | 118.1 | 92.2 | 144.0 | 155.3 | 194.5 | 75.9 | 80.8 | 47.6 | 89.5 | 53.0 | 70.4 |
| Long-Term Assets | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 12.2 | 12.5 | 12.9 | 13.2 | 13.6 | 14.0 | 14.3 | 14.7 | 15.0 | 15.4 | |
| Goodwill | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Intangible Assets | 0.0 | 0.0 | 0.0 | 0.1 | 0.2 | 0.2 | 0.1 | 0.2 | 0.2 | 0.3 | |
| Long-Term Investments | 20.9 | 20.9 | 20.9 | 21.0 | 21.1 | 23.0 | 22.0 | 19.6 | 16.1 | 16.5 | |
| Other Long-Term Assets | 1.9 | 1.9 | 1.9 | 1.9 | 2.0 | 0.0 | 2.0 | 0.0 | 2.0 | 2.0 | |
| Total Long-Term Assets | 35.0 | 35.3 | 35.7 | 36.2 | 36.8 | 37.2 | 38.4 | 34.4 | 33.3 | 34.1 | |
| Total Assets | 63.8 | 77.4 | 81.7 | 92.2 | 102.7 | 118.1 | 131.6 | 144.0 | 125.0 | 136.2 |
| Current Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 4.7 | 3.2 | 3.7 | 2.0 | 7.1 | 5.4 | 3.3 | 3.8 | 2.0 | 0.9 | 0.7 | |
| Short-Term Debt | 1.3 | 1.3 | 1.2 | 0.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Current Liabilities | 8.1 | 6.0 | 6.5 | 4.5 | 7.7 | 14.4 | 7.3 | 5.1 | 4.0 | 2.9 | 1.6 | |
| Current Liabilities | 14.1 | 10.5 | 11.5 | 7.0 | 14.8 | 22.1 | 10.5 | 8.8 | 6.0 | 3.7 | 2.3 |
| Current Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 1.7 | 4.0 | 2.0 | 3.2 | 2.7 | 4.7 | 3.6 | 3.7 | 1.2 | 3.8 | |
| Short-Term Debt | 1.4 | 1.4 | 1.4 | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 | 1.2 | 0.9 | |
| Other Current Liabilities | 3.0 | 3.6 | 6.0 | 6.0 | 7.6 | 8.1 | 4.0 | 6.5 | 6.2 | 5.4 | |
| Current Liabilities | 6.8 | 8.9 | 9.3 | 10.5 | 11.6 | 14.1 | 8.9 | 11.5 | 8.7 | 10.1 |
| Long-Term Liabilities | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 1.0 | 13.4 | 14.8 | 16.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 14.1 | 14.8 | 16.0 | 16.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 29.2 | 23.9 | 56.2 | 23.0 | 14.8 | 32.3 | 10.8 | 8.8 | 6.0 | 3.7 | 2.3 |
| Long-Term Liabilities | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 0.0 | 12.7 | 13.1 | 13.4 | 13.8 | 15.1 | 14.4 | 14.8 | 15.1 | 15.4 | |
| Capital Leases | 1.4 | 14.1 | 14.4 | 14.8 | 15.1 | 14.1 | 15.7 | 14.8 | 16.3 | 16.3 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 19.2 | 21.6 | 22.4 | 23.9 | 26.4 | 29.2 | 53.3 | 56.2 | 23.7 | 25.5 |
| Total Common Equity | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -281.0 | -304.3 | -277.9 | -225.5 | -171.4 | -294.2 | -213.2 | -152.7 | -100.7 | -61.8 | -13.5 | |
| Comprehensive Income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.1 | 0.0 | 0.0 | |
| Total Common Equity | 88.9 | 68.2 | 87.8 | 132.3 | 179.7 | 43.6 | 70.0 | 38.8 | 83.4 | 49.3 | 68.1 |
| Total Common Equity | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Retained Earnings | -331.4 | -319.2 | -314.5 | -304.3 | -295.0 | -281.0 | -289.6 | -277.9 | -262.5 | -251.3 | |
| Comprehensive Income | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Common Equity | 44.7 | 55.8 | 59.3 | 68.2 | 76.3 | 88.9 | 78.3 | 87.8 | 101.3 | 110.7 |
| Other | TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 16.4 | 14.8 | 16.0 | 16.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 88.9 | 68.2 | 87.8 | 132.3 | 179.7 | 43.6 | 70.0 | 38.8 | 83.4 | 49.3 | 68.1 |
| Other | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 44.7 | 55.8 | 59.3 | 68.2 | 76.3 | 88.9 | 78.3 | 87.8 | 101.3 | 110.7 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -29.7 | -17.4 | -26.4 | -52.3 | -54.2 | 122.8 | -81.0 | -60.5 | -52.0 | -64.8 | -22.4 | -13.2 | |
| Depreciation & Amortization | 1.1 | 0.3 | 0.6 | 1.6 | 1.4 | 0.2 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | |
| Stock-Based Compensation | 7.1 | 4.8 | 6.3 | 7.3 | 6.6 | 5.1 | 7.5 | 5.2 | 7.1 | 6.4 | 3.6 | 1.5 | |
| Change Working Capital | 6.1 | -4.1 | -0.2 | 2.4 | -8.2 | -16.8 | 21.8 | 3.9 | -0.8 | 1.0 | 0.9 | 1.8 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 1.0 | -1.2 | -0.5 | 1.8 | -5.2 | 1.7 | 2.3 | -0.7 | 1.6 | 1.1 | 0.2 | 0.6 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -34.5 | -21.9 | -36.3 | -4.7 | -0.8 | 7.3 | -0.2 | 0.0 | 0.0 | 25.9 | 3.6 | 4.4 | |
| Cash from Operations | -52.9 | 0.0 | 0.0 | -45.8 | -55.2 | 118.6 | -51.6 | -51.1 | -45.6 | -31.5 | -17.8 | -5.5 |
| Cash Flow From Operating Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 9.7 | -12.2 | -4.7 | -10.2 | -9.3 | -14.0 | 8.5 | -11.7 | -15.3 | -11.3 | |
| Depreciation & Amortization | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.4 | 0.4 | |
| Stock-Based Compensation | 1.2 | 0.0 | 1.2 | 1.3 | 0.0 | 0.0 | 0.0 | 2.0 | 1.8 | 1.6 | |
| Change Working Capital | 0.1 | -1.7 | -1.2 | -1.3 | -0.9 | -1.7 | 4.2 | -1.7 | 3.7 | 0.0 | |
| Change In Accounts Receivable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.2 | -2.2 | 2.0 | -1.2 | 0.5 | -2.0 | 1.1 | -0.1 | 2.5 | -2.5 | |
| Change In Inventories | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -21.4 | 1.0 | -0.2 | -0.2 | 0.0 | 0.6 | -27.1 | -5.4 | -2.3 | -1.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -11.9 | -10.1 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | 0.0 | -0.1 | 0.0 | -1.4 | -0.2 | -0.4 | -0.2 | -0.4 | 0.0 | -0.2 | -0.1 | |
| Acquisitions | 52.9 | 0.0 | 0.0 | 0.0 | -2.5 | -1.6 | 0.3 | 0.2 | 0.3 | 0.0 | 0.0 | 0.0 | |
| Investments | -134.7 | -91.9 | -73.2 | -112.4 | -173.0 | -1,632.0 | -10.0 | -34.8 | -50.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 115.0 | 42.0 | 128.0 | 120.0 | 90.0 | 1,637.4 | 45.0 | 5.0 | 45.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | -32.6 | 0.0 | 0.0 | -10.1 | -1.0 | -5.4 | -0.3 | -0.2 | -0.3 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | -19.9 | 0.0 | 0.0 | -2.6 | -87.9 | -1.8 | 34.6 | -30.0 | -5.4 | 0.0 | -0.2 | -0.1 |
| Cash Flow From Investing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 48.5 | 4.4 | |
| Investments | -77.1 | -4.9 | -4.9 | -4.9 | -16.7 | -9.7 | -37.0 | -9.8 | -58.5 | -29.4 | |
| Sales of Investment | 5.0 | 10.0 | 17.0 | 10.0 | 38.0 | 10.0 | 50.0 | 30.0 | 10.0 | 25.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -48.5 | -4.4 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -48.5 | -4.4 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -30.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 30.0 | 14.8 | -1.2 | -0.5 | 16.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 0.8 | 0.0 | 0.0 | 0.5 | 180.7 | 0.0 | 46.7 | 86.4 | 0.0 | 69.8 | 0.0 | 0.0 | |
| Repurchase of Common Stock | -15,448.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 30.5 | 0.0 | 0.0 | 30.5 | -180.5 | 0.9 | 0.3 | 0.1 | 0.3 | -3.0 | 0.0 | 70.6 | |
| Cash from Financing | 30.8 | 0.0 | 0.0 | 30.5 | 0.2 | 0.9 | 47.1 | 86.5 | 0.3 | 66.7 | 0.0 | 70.6 |
| Cash Flow From Financing Activities | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 1.4 | -12.7 | -0.3 | -0.3 | -0.3 | -1.3 | 0.7 | -30.3 | 29.7 | 0.0 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -15,448.8 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 30.0 | 0.2 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 30.0 | 0.2 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -41.9 | -13.1 | -0.7 | -17.8 | -142.9 | 117.7 | 30.1 | 5.4 | -50.6 | 35.2 | -18.0 | 65.1 | |
| Closing Cash Balance | 29.7 | 15.1 | 28.2 | 29.0 | 46.8 | 189.7 | 72.0 | 41.9 | 36.5 | 87.1 | 51.9 | 69.9 |
| Cash position | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -7.5 | -7.8 | 7.3 | -5.2 | 11.3 | -14.7 | -1.1 | 3.7 | -30.4 | -14.2 | |
| Closing Cash Balance | 15.1 | 20.6 | 30.3 | 23.1 | 26.3 | 15.0 | 29.7 | 30.8 | 27.0 | 59.4 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -53.0 | -38.3 | -56.0 | -45.9 | -56.6 | 118.4 | -52.0 | -51.3 | -45.9 | -31.5 | -18.0 | -5.5 | |
| Real Free Cash Flow | -60.1 | -43.1 | -62.3 | -53.2 | -63.2 | 113.4 | -59.5 | -56.5 | -53.0 | -37.9 | -21.6 | -7.0 |
| Free Cash Flow | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -10.4 | -12.9 | -4.8 | -10.3 | -10.0 | -15.0 | -14.3 | -16.7 | -11.9 | -10.1 | |
| Real Free Cash Flow | -11.6 | -12.9 | -6.0 | -11.6 | -10.0 | -15.0 | -14.3 | -18.7 | -13.7 | -11.7 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -2.9 | -2 | -1.4 |
| P/S | 16.1 | 135.2 | 9.4 |
| P/B | 2.4 | 2.4 | 5.2 |
| P/FCF | -2.6 | -2.6 | -1.5 |
| Market cap | $0.1 | $0.8 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 2.2 % | 19.5 % | 0 % |
| Debt to Income | -8.1 % | -7.9 % | 0 % |
| Debt to Free cash flow | -3.4 % | -258 % | 0 % |
| Interest expense percentage | 0 % | 42.6 % | 44.7 % |
| Current ratio | 4.2 | 9.8 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -39 % | 93.6 % | 0 % |
| ROA | -27.3 % | 70.6 % | 0 % |
| CapEx to Revenue | -0.1 % | 38.7 % | 0 % |
| RaD to Revenue | 0 % | 1986.1 % | 0 % |
| ROEM | 315,304.3 | -527665 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | 99.7 % | 8740.6 % | 68.7 % |
| Operating margin | -618.3 % | -4137.2 % | 35.5 % |
| Net margin | -549.6 % | 73693.3 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 71.1 mil | 50.5 mil |
| Employee count | 0.0 tis | 0.0 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
